Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
|
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 47 条
  • [1] Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study
    Amitay, Efrat L.
    Cuk, Katarina
    Niedermaier, Tobias
    Weigl, Korbinian
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2419 - 2427
  • [2] False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening
    van Rossum, Leo G. M.
    van Rijn, Anne F.
    van Oijen, Martijn G. H.
    Fockens, Paul
    Laheij, Robert J. F.
    Verbeek, Andre L. M.
    Jansen, Jan B. M. J.
    Dekker, Evelien
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 746 - 750
  • [3] How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis
    Haug, Ulrike
    Knudsen, Amy B.
    Kuntz, Karen M.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (09) : 2094 - 2102
  • [4] Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests
    Meklin, Jannica
    Syrjanen, Kari
    Eskelinen, Matti
    ANTICANCER RESEARCH, 2020, 40 (02) : 575 - 581
  • [5] Risk factors for false positive and for false negative test results in screening with fecal occult blood testing
    Stegeman, Inge
    de Wijkerslooth, Thomas R.
    Stoop, Esther M.
    van Leerdam, Monique
    van Ballegooijen, M.
    Kraaijenhagen, Roderik A.
    Fockens, Paul
    Kuipers, Ernst J.
    Dekker, Evelien
    Bossuyt, Patrick M.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (10) : 2408 - 2414
  • [6] Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008
    Choi, Kui Son
    Lee, Hoo-Yeon
    Jun, Jae Kwan
    Shin, Aesun
    Park, Eun-Cheol
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (06) : 1070 - 1077
  • [7] Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?
    Quintero, Enrique
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (08): : 565 - 576
  • [8] Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases
    Nishida, Hiroshi
    Urano, Sumio
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (03) : 184 - 189
  • [9] Trends in Colorectal Cancer Screening With Home-Based Fecal Occult Blood Tests in Adults Ages 50 to 64 Years, 2000-2008
    Bandi, Priti
    Cokkinides, Vilma
    Smith, Robert A.
    Jemal, Ahmedin
    CANCER, 2012, 118 (20) : 5092 - 5099
  • [10] Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: Modeling the impact on colonoscopy requirements and cancer detection rates
    Olynyk, JK
    Platell, CF
    Collett, JA
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (04) : 389 - 392